TSXV - Delayed Quote CAD

Many Bright Ideas Technologies Inc. (MBI-H.V)

0.0800 -0.0150 (-15.79%)
At close: April 25 at 3:55 PM EDT
Loading Chart for MBI-H.V
DELL
  • Previous Close 0.0950
  • Open 0.0500
  • Bid 0.0250 x --
  • Ask 0.0850 x --
  • Day's Range 0.0250 - 0.0800
  • 52 Week Range 0.0100 - 0.1500
  • Volume 13,496
  • Avg. Volume 3,277
  • Market Cap (intraday) 1.381M
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer. It focuses on the commercialization of technologies in various industrial sectors. The company was formerly known as Med BioGene Inc. and changed its name to Many Bright Ideas Technologies Inc. in June 2022. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

www.medbiogene.com

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: MBI-H.V

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MBI-H.V
700.00%
S&P/TSX Composite index
4.42%

1-Year Return

MBI-H.V
700.00%
S&P/TSX Composite index
5.85%

3-Year Return

MBI-H.V
27.27%
S&P/TSX Composite index
14.57%

5-Year Return

MBI-H.V
60.00%
S&P/TSX Composite index
31.95%

Compare To: MBI-H.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MBI-H.V

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    1.38M

  • Enterprise Value

    1.38M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -23.74

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -1,082.74%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -58.11k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    713

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    32.32k

Company Insights: MBI-H.V

People Also Watch